Issue 1/2020

Understanding the crosstalk of molecular factors and signaling pathways reveals novel biomarkers of cisplatin resistance in testicular germ cell tumors (1 — 14)

Jan Roska,  Dana Jurkovicova

DOI: 10.4149/neo_2019_190318N244

PCNA and GSK3β interact with each other to regulate H1299 lung adenocarcinoma cells apoptosis (15 — 26)

Xiao-Hui Liu, Dong-E Tang, Yong Dai,  Xue-Juan Gao,  Lang-Xia Liu

DOI: 10.4149/neo_2019_190116N48

Preliminary evaluation of GLP-1R PET in the diagnosis and risk stratification of pheochromocytomas (27 — 36)

Mingzhu Li, Yu Liu, Yuping Xu, Yaoqi Li, Donghui Pan, Lizhen Wang, Junjie Yan, Xinyu Wang, Runlin Yang,  Min Yang

DOI: 10.4149/neo_2019_190227N163

STIL is upregulated in nasopharyngeal carcinoma tissues and promotes nasopharyngeal carcinoma proliferation, migration and invasion (37 — 45)

Ying Ouyang, Ya-Bin Jin, Xiang-Ping Chen, Guo-Yi Zhang, Shao-Long Mao,  Fei Ling,  Wei Luo

DOI: 10.4149/neo_2019_190306N192

HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling (46 — 53)

Xiang-Geng Chi, Xiang-Xin Meng, De-Liang Ding, Xing-Hua Xuan, Yan-Zhuan Chen, Qi Cai,  Ang Wang

DOI: 10.4149/neo_2019_190217N135

Second-generation Src/Abl inhibitor bosutinib effectively induces apoptosis in human esophageal squamous cell carcinoma (ESCC) cells via inhibiting Src/Abl signaling (54 — 60)

Yi-Nuer Ha, Yueme Dai, Dilinuer Wufuer, Muyeshaer Pidayi, Gulidana Anasihan,  Lin Chen

DOI: 10.4149/neo_2019_190131N94

An indel polymorphism in the 3′ untranslated region of HMGB1 confers risk for hepatocellular carcinoma by regulating HMGB1 transcriptional activity in a Chinese population (61 — 67)

Jian Wang, Jian Zhu, Dong-Hua Mao, Sheng Zhu, Xiao-Guang Mi,  Qiang Yu

DOI: 10.4149/neo_2019_190221N147

Upregulated circZMIZ1 promotes the proliferation of prostate cancer cells and is a valuable marker in plasma (68 — 77)

Hua Jiang, Dao-Jun Lv, Xian-Lu Song, Chong Wang, Yu-Zhong Yu,  Shan-Chao Zhao

DOI: 10.4149/neo_2019_190213N116

High eukaryotic translation elongation factor 1 alpha 1 expression promotes proliferation and predicts poor prognosis in clear cell renal cell carcinoma (78 — 84)

Yi Bao, Tang-Liang Zhao, Z-Q Zhang, Xiao-Long Liang, Zhi-Xiang Wang, Ying Xiong, Xin Lu,  Lin-Hui Wang

DOI: 10.4149/neo_2019_190224N158

MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4 (85 — 92)

 Zhi Cui, Qi-Lin Liu, Shi-Qun Sun, Kun Jiao, Dong-Rui Liu, Xue-Chun Zhou, Lei Huang

DOI: 10.4149/neo_2019_190306N191

MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells (93 — 101)

Ying Zuo, Wei Zheng, Jing Liu, Qing Tang, Shan-Shan Wang,  Xing-Sheng Yang

DOI: 10.4149/neo_2019_190202N106

MiR-512-3p regulates malignant tumor behavior and multi-drug resistance in breast cancer cells via targeting Livin (102 — 110)

 Wen-Jing Duan, Pin-Duan Bi, Yun Ma, Nian-Qu Liu, Xi Zhen

DOI: 10.4149/neo_2019_190106N18

LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis (111 — 118)

Zheng-Zheng Liu, Yi-Fu Tian, Heng Wu, Shu-Yu Ouyang,  Wei-Lu Kuang

DOI: 10.4149/neo_2019_190121N61

Decreased expression of SorCS1 in colorectal cancer: An independent predictor of poor prognosis (119 — 128)

Pin-Zhu Huang, Shao-Yong Peng, Hui-Chuan Yu, Liang Huang, Qi Yao, Xiao-Lin Wang, Shu-Yun Tan, Jia-Ming Zhou, Pu-Ning Wang, An-Pei Huang, Liang-Liang Bai, Yan-Xin Luo,  Mei-Jin Huang

DOI: 10.4149/neo_2019_190221N146

Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway (129 — 136)

Shi-Bo Liu, Li-Bin Zhou, Hai-Feng Wang, Gang Li, Qing-Peng Xie,  Bin Hu

DOI: 10.4149/neo_2019_190206N108

Identification of urinary hsa_circ _0137439 as potential biomarker and tumor regulator of bladder cancer (137 — 146)

Zhengyao Song, Qinghua Zhang, Jiangbo Zhu, Guolin Yin, Li Lin,  Chaozhao Liang

DOI: 10.4149/neo_2018_181214N970

miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs) (147 — 157)

Xiayan Liu, Xiangdong Zhou, Yongfeng Chen, Ying Huang, Jian He,  Hu Luo

DOI: 10.4149/neo_2019_190511N420

BCR/ABL preleukemic fusion gene in subpopulations of hematopoietic stem and progenitor cells from human UCB (158 — 163)

Lukáš Jakl, Milan Škorvaga, Katarína Bérešová, Pavol Košík, Matúš Durdík, Jana Jakubíková, Marek Holop, Miroslav Kubeš, Lucián Zastko, Eva Marková,  Igor Beliaev

DOI: 10.4149/neo_2019_190925N965

Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors (164 — 170)

 David Kalfert, Marie Ludvikova, Ivana Kholova,  Jaroslav Ludvik, Ondrej Topolocan, Jan Plzak

DOI: 10.4149/neo_2019_190128N86

Circular RNA circHIPK3 serves as a prognostic marker to promote chronic myeloid leukemia progression (171 — 177)

Xian-Qi Feng, Shu-Min Nie, Jun-Xia Huang, Tian-Lan Li, Jing-Jing Zhou, Wei Wang,  Li-Kun Zhuang,  Fan-Jun Meng

DOI: 10.4149/neo_2018_181129N908

Bortezomib retreatment is effective in relapsed multiple myeloma patients – real-life clinical practice data (178 — 184)

Martin Štork, Sabina Ševčíková, Lucie Brožová, Ivan Špička, Vladimír Maisnar, Jiří Minařík, Alexandra Jungová, Evžen Gregora, Roberta Velichová, Roman Hájek, Tomáš Jelínek,  Luděk Pour

DOI: 10.4149/neo_2019_190430N383

Chromosomal aberrations in ascetic fluid of metastatic gastric cancer patients: A clustering analysis (185 — 192)

Tarlan Nayebbagher, Hossein Pashaiefar,  Marjan Yaghmaie, Kamran Alimoghaddam, Mahdi Jalili, Mohsen Esfandbod, Masoumeh Saberian, Hadiseh Behroozi, Marzie Izadifard, Ardeshir Ghavamzadeh

DOI: 10.4149/neo_2019_190202N105

4DCT-based evaluation of lung tumour motion during the breathing cycle (193 — 202)

 Marta Adamczyk, Marek Konkol, Mirosława Matecka-Nowak, Tomasz Piotrowski

DOI: 10.4149/neo_2019_190309N206

Hepatitis B virus infection status is not associated with poor prognosis in classical Hodgkin lymphoma patients (203 — 208)

Bing Bu, Kun Yi, Hongmei Wang, Mingzi Yang, Meng Wu, Lingyan Ping, Yan Xie, Juan Qiu, Linjun Zhao, Di Mei, Xiaopei Wang, Yuqin Song, Jun Zhu,  Weiping Liu

DOI: 10.4149/neo_2019_190211N113

Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: A single center experience. (209 — 213)

Michiel Bronswijk, Annouschka Laenen,  Oliver Bechter

DOI: 10.4149/neo_2019_190105N17